Press "esc" to clear
Go to Advanced Search

Showing results

110 of 2311

Article ID: 700795

Grad Student Wins AHA Fellowship to Study Diabetes’ Effects on the Heart

West Virginia University

Diabetics are at least twice as likely as nondiabetics to die of heart disease. They’re also at a greater risk of heart attack. With a two-year, $53,000 fellowship from the American Heart Association, Quincy Hathaway, a doctoral candidate in the West Virginia University School of Medicine, is examining how a certain protein, called PNPase, influences mitochondria’s performance in heart cells.

20-Sep-2018 8:30 AM EDT

Article ID: 700742

Johns Hopkins and Cleveland Clinic Team Up to Participate in $20 Million Award to Study Sugar Molecules

Johns Hopkins Medicine

$20 million will fund four academic centers to launch the National Career Development Consortium for Excellence in Glycosciences Training

19-Sep-2018 8:00 PM EDT

Article ID: 700772

Anti-inflammatory Protein Promotes Healthy Gut Bacteria to Curb Obesity

University of North Carolina School of Medicine

UNC Scientists discovered the anti-inflammatory protein NLRP12 helps protect mice against obesity and insulin resistance when fed a high-fat diet. The researchers also reported the NLRP12 gene is underactive in people who are obese, making it a therapeutic target for treating obesity and diabetes.

19-Sep-2018 10:45 AM EDT
Embargo will expire:
24-Sep-2018 12:05 AM EDT
Released to reporters:
18-Sep-2018 8:05 PM EDT


A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2018 12:05 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Article ID: 700601

Mannose’s Unexpected Effects on the Microbiome and Weight Gain

Sanford Burnham Prebys Medical Discovery Institute

Scientists continue to unravel links between body weight and the gut microbiome. Now, researchers from Sanford Burnham Prebys Medical Discovery Institute (SBP) report an unexpected finding: mice fed a fatty diet and mannose, a sugar, were protected from weight gain, leaner and more fit—and this effect tracked with changes in the gut microbiome. The study published today in Cell Reports.

18-Sep-2018 11:00 AM EDT

Article ID: 700592

Renowned Expert to Lead Center for Diabetes & Metabolic Health

NYU Langone Health

Lauren H. Golden, MD, a nationally renowned clinician, has been appointed director of the Center for Diabetes & Metabolic Health at NYU Langone Health to augment the institution’s efforts and reputation for excellence in diabetes care.

18-Sep-2018 10:00 AM EDT

Article ID: 700671

Study Reveals the Current Rates of Diagnosed Type 1 and Type 2 Diabetes in American Adults

University of Iowa

A new study from the University of Iowa finds that type 2 diabetes is overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease. The study found that among Americans who are diagnosed with diabetes, 91.2 percent have type 2 and 5.6 percent have type 1.

17-Sep-2018 4:10 PM EDT

Article ID: 700624

Case Western Reserve School of Medicine Receives NIH Funding to Investigate New Imaging Approach for Peripheral Vascular Disease

Case Western Reserve University

Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.

17-Sep-2018 10:05 AM EDT

Article ID: 700377

An Old Drug Finds New Purpose Against Retinal Neovascularization

Sanford Burnham Prebys Medical Discovery Institute

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have found that the anti-malaria drug amodiaquine inhibits the apelin receptor protein, which helps drive the vascularization behind diabetic retinopathy, wet age-related macular degeneration (AMD) and other conditions. Because the drug has been approved to treat malaria for decades, it could move relatively quickly through the pipeline to help patients. The study was published in the journal PLOS ONE.

12-Sep-2018 2:00 PM EDT

Article ID: 700309

National Diabetes Coalition Urges People with Diabetes in the East Coast to Prepare for Hurricane Florence

Endocrine Society

As the U.S. Eastern seaboard braces for Hurricane Florence, a category 4 hurricane that could potentially impact several states including Georgia, South Carolina, North Carolina and Virginia between Thursday and Friday, the diabetes community is rallying to make sure that people living with diabetes—especially those who depend upon insulin—are fully supported. The Diabetes Disaster Response Coalition (DDRC), which is comprised of the Endocrine Society and other leading diabetes organizations, is urging all people with diabetes and their loved ones to prepare for Hurricane Florence by putting together a diabetes kit and making a plan to stay healthy and safe during the storm and in its aftermath.

11-Sep-2018 10:35 AM EDT

Showing results

110 of 2311

Chat now!